Company: BFRG
Filing Date: 2025-03-14
Form Type: 10-K
Source: 0001493152-25-010367
Chunk: 71

Company: BullFrog AI Holdings, Inc.
Filing Date: 2025-03-14
Form: 10-K
Item: Item 1
Chunk 71
---
 challenging to license them under favorable terms in order to create value for shareholders. Subsequent development
of these assets for clinical testing may require significant effort and resources. Ultimately, these assets must undergo rigorous clinical
testing and approval by FDA or comparable regulatory authorities in other countries in order to be marketed. A key part of our strategy
is to partner our R&D programs. In addition, we do not intend on commercializing drugs and instead will seek to divest each drug
asset to a company that will commercialize the drug. The Company may receive future royalties in some transactions.

The
following graphic illustrates the global revenue forecast for applying AI in the pharmaceutical industry, as well as the increase in
anticipated market spend and annual growth rate for AI solutions per certain application areas.

 12 

Intellectual
Property

Patents

We
have exclusive worldwide rights to the following patents related to our intellectual property:

Mebendazole
Polymorph For Treatment And Prevention Of Tumors

    Serial
    Number
     
    Country
     
    Status
     
    Issue
    Date
     
    Expiration
    Date
  
    62/112,706
     
    United States
     
    Converted
     
    N/A
     
    N/A
  
    PCT/US2016/016968
     
    PCT
     
    Nationalized
     
    N/A
     
    N/A
  
    11,110,079
     
    United States
     
    Granted
     
    9/7/2021
     
    2/8/2036
  
    17/402,131
     
    United States
     
    Abandoned
     
    N/A
     
    N/A
  
    18/525,209
     
    United States
     
    Pending
     
    N/A
     
    N/A
  
    16747414.7
     
    Europe
     
    Granted
     
    12/15/2021
     
    2/8/2036
  
    16747414.7
     
    Czech Republic
     
    Granted
     
    12/15/2021
     
    2/8/2036
  
    16747414.7
     
    France
     
    Granted
     
    12/15/2021